University of New South Wales: Commonly Prescribed Kidney Medication 'Ineffective' - Clinical Trial
June 25, 2020
June 25, 2020
SYDNEY, Australia, June 25 -- The University of New South Wales issued the following news release:
Medication prescribed to one in five chronic kidney disease patients is ineffective, a major clinical trial has found.
Allopurinol does not prevent worsening of kidney disease - despite up to 20 per cent of kidney disease patients being prescribed the medication, results of a major clinical trial have revealed.
Researchers from UNSW and The George Institute fo . . .
Medication prescribed to one in five chronic kidney disease patients is ineffective, a major clinical trial has found.
Allopurinol does not prevent worsening of kidney disease - despite up to 20 per cent of kidney disease patients being prescribed the medication, results of a major clinical trial have revealed.
Researchers from UNSW and The George Institute fo . . .